← Eichor
Condition: Glioblastoma Multiforme Gbm Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Glioblastoma Multiforme Gbm

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT00083512Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma
Phase 1 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT05083754Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
Phase 1 · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT05366179Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Gl
Phase 1/Phase 2 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT06059690HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Phase 1/Phase 2 · 1 location(s) · The Methodist Hospital Research Institute · NCT03603405Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared
Phase 3 · 1 location(s) · Northwell Health · NCT052712405G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours
Phase 1/Phase 2 · 3 location(s) · Institute of Cancer Research, United Kingdom · NCT06630260Evaluate the Efficacy and Safety of ADCV01 As an Add-On Treatment for Primary Glioblastoma Multiforme (GBM) Patients
Phase 2 · 3 location(s) · Ever Supreme Bio Technology Co., Ltd. · NCT04115761WBSI Guided Personalized Delivery of TTFields
NA · 2 location(s) · Abramson Cancer Center at Penn Medicine · NCT05086497Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Ref
Phase 2 · 1 location(s) · Northwell Health · NCT028004865G-PEARL: Paxalisib in Malignant Brain Tumours
Phase 1/Phase 2 · 1 location(s) · Institute of Cancer Research, United Kingdom · NCT07391215A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combinatio
Phase 2 · 5 location(s) · Cedars-Sinai Medical Center · NCT05708352Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning
Phase N/A · 1 location(s) · Washington University School of Medicine · NCT05864976Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Phase 1/Phase 2 · 2 location(s) · University of Arizona · NCT06814496APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Phase 2 · 35 location(s) · Apollomics Inc. · NCT03175224The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients.
NA · 5 location(s) · Jasper Gerritsen · NCT03861299hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)
Phase 2 · 1 location(s) · Leland Metheny · NCT05052957Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.
Phase 1 · 1 location(s) · Henry Ford Health System · NCT05686798Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma
Phase 2 · 1 location(s) · Northwestern University · NCT05864534Low-Intensity Oscillatory Magnetic Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) - An Exposure-
NA · 6 location(s) · BioTex, Inc. · NCT06533163Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue
Phase N/A · 1 location(s) · Baptist Health South Florida · NCT05756985The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
Phase N/A · 8 location(s) · Jasper Gerritsen · NCT06146725Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
Phase 1/Phase 2 · 1 location(s) · University of Miami · NCT05956821Prognostic Potential of Olfactory Function in Glioblastoma: a Prospective Observational Study
Phase N/A · 2 location(s) · Sied Kebir · NCT06954636NK Cell Therapy for Malignant Solid Brain Tumors
NA · 4 location(s) · Peking University Third Hospital · NCT07552233Early Phase Study of KESONOTIDE™in Participants With Solid Tumours
Phase 1/Phase 2 · 3 location(s) · Filamon LTD · NCT06926075Atezolizumab and Pre-Surgical Brain Radiation Therapy for Glioblastoma Multiforme
EARLY_Phase 1 · 1 location(s) · Stony Brook University · NCT05423210Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Phase 2 · 22 location(s) · Black Diamond Therapeutics, Inc. · NCT07326566Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma
NA · 1 location(s) · Northwell Health · NCT05954858The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
Phase N/A · 8 location(s) · Jasper Gerritsen · NCT06283927
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.